Adam Harrington to Humans
This is a "connection" page, showing publications Adam Harrington has written about Humans.
Connection Strength
0.056
-
Functional analysis of VPS41-mediated neuroprotection in Caenorhabditis elegans and mammalian models of Parkinson's disease. J Neurosci. 2012 Feb 08; 32(6):2142-53.
Score: 0.015
-
Caenorhabditis elegans as a model system for identifying effectors of a-synuclein misfolding and dopaminergic cell death associated with Parkinson's disease. Methods. 2011 Mar; 53(3):220-5.
Score: 0.014
-
Peripheral Auditory Nerve Impairment in a Mouse Model of Syndromic Autism. J Neurosci. 2022 10 19; 42(42):8002-8018.
Score: 0.008
-
Emerging roles for MEF2 in brain development and mental disorders. Curr Opin Neurobiol. 2019 12; 59:49-58.
Score: 0.006
-
Modeling dopamine neuron degeneration in Caenorhabditis elegans. Methods Mol Biol. 2011; 793:129-48.
Score: 0.003
-
Low-dose bafilomycin attenuates neuronal cell death associated with autophagy-lysosome pathway dysfunction. J Neurochem. 2010 Aug; 114(4):1193-204.
Score: 0.003
-
VPS41, a protein involved in lysosomal trafficking, is protective in Caenorhabditis elegans and mammalian cellular models of Parkinson's disease. Neurobiol Dis. 2010 Feb; 37(2):330-8.
Score: 0.003
-
Application of a C. elegans dopamine neuron degeneration assay for the validation of potential Parkinson's disease genes. J Vis Exp. 2008 Jul 18; (17).
Score: 0.003